IRICoR receives 25 million dollars to support its research commercialization activities as part of the 2018 CECR competition

Montreal, July 30, 2018 — IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), a drug discovery and commercialization cluster, is proud to announce that it has received substantial support from the federal government in the amount of 25 million dollars, as part of the 2018 edition of the Centres of Excellence […]

Two IRIC investigators receive a grant from the Canadian Institutes of Health Research

Kathy Borden and Marc Therrien each recently received a grant from the Canadian Institutes of Health Research (CIHR), respectively as part of the Project Grant: Spring 2018 competition and the Foundation Grant: 2017-2018 competition. Kathy Borden, Principal Investigator, Structure and Function of the Cell Nucleus research unit at the IRIC and Full Professor, Department of […]

Appointment of Robert Paré and renewal of Jacques Bernier’s mandate on the IRIC’s Board of Directors

The IRIC is pleased to announce the appointment of Mtre Robert Paré as a new member of the Board of Directors as well as the renewal of Mr. Jacques Bernier’s mandate as a member of the Board by the Executive Committee of the Université de Montréal. Mtre Robert Paré, Strategic Advisor with Fasken, has been […]

Renewal of Michel Bouvier’s mandate as Chief Executive Officer of the IRIC

Following a meeting of the Executive Committee, held on June 12, the Université de Montréal announced the continuation of Michel Bouvier’s mandate as Chief Executive Officer of the IRIC for a second four-year term. Mr. Bouvier is a Full Professor in the Department of Biochemistry and Molecular Medicine of the Université de Montréal’s Faculty of […]

Thanks to the Blais Family Fund Golf Tournament, $70 000 was raised to support the research against cancer at the IRIC

More than 144 golfers gathered at the Buckingham Golf Club on July 6th for the Blais Family Fund Golf Tournament. $70 000 was raised to support the research against cancer at the IRIC. Pierre Blais, founder of the Blais Family Fund Golf Tournament, survived cancer thanks to an innovative procedure suggested by Dr. Sauvageau, Principal Investigator […]

UM171 Molecule: Completion of Phase I/II clinical trial for the treatment of blood cancer patients

On June 12, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal celebrated 10 years of activity for its medicinal chemistry core facility, the largest of its kind in a university setting in Canada. Today, the IRIC announces the completion of Phase I/II of the clinical trial testing the efficacy […]

When the gatekeeper drops its guard

By Martin Primeau Jean-Claude Labbé’s research team at the IRIC published a study that suggests why certain anti-cancer drugs have variable effectiveness depending on the type of cancer. The results of this research were recently published in the journal Molecular Biology of the Cell. The researchers were interested in a cellular quality-control system called “spindle […]

Krystel Vincent to participate in the Lindau Nobel Laureate Meeting in Germany

Krystel Vincent will participate in the 68th Lindau Nobel Laureate Meeting, which will take place from June 24 to 29 in Germany. Selected by the Scientific Examination Committee of the event’s Council, she received the distinction by virtue of the scope of her work carried out with Céline Laumont on identifying targets on cancer cells […]

Announcing the 2018 IRIC Next Generation Awards recipients

This summer, 18 students will have the chance this summer to conduct a research internship at the Institute, for 12 or 16 weeks and will receive an undergraduate research award, a value of $4,250 or $5,670. This opportunity is made possible thanks to 2018 IRIC Next Generation Awards, the financial contribution from a few of […]

« Previous Page | Next Page »

Follow IRIC

Logo UdeM